EHC

Encompass Health Corporation

64.32 USD

Last updated Nov 30, 07:50 UTC

Yesterday HIGH

$65.21

Yesterday LOW

$64.27

52w HIGH

$72.06

52w LOW

$51.15

EPS

0.86

PE

74.79

Next Earnings

Feb 6, 2024

Dividends yield

0.93%

Overview News Insider Transactions Government Trades

Encompass Health Corporation stock is up 2.81% since 30 days ago. The dividend yield is 0.93% and its next earnings date is Feb 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 63.16% of the previous 37 November’s closed higher than October.

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. As of April 11, 2022, it operated 147 hospitals, 251 home health locations, and 96 hospice locations in 42 states and Puerto Rico.

Stock Exchange

NYSE

Sector

Services

Industry

Healthcare

Headquarters

Birmingham, United States Of America

Website

encompasshealth.com

Benzinga Insights

Thu Jun 29, 2023

What 9 Analyst Ratings Have To Say About Encompass Health
richadhand@benzinga.com

Thu Jun 29, 2023

Stephens & Co. Maintains Overweight on Encompass Health, Raises Price Target to $78

Stephens & Co. analyst Scott Fidel maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $74 to $78.
richadhand@benzinga.com

Tue May 2, 2023

RBC Capital Maintains Outperform on Encompass Health, Raises Price Target to $70

RBC Capital analyst Ben Hendrix maintains Encompass Health (NYSE:EHC) with a Outperform and raises the price target from $66 to $70.
richadhand@benzinga.com

Tue May 2, 2023

Raymond James Maintains Strong Buy on Encompass Health, Raises Price Target to $80

Raymond James analyst John Ransom maintains Encompass Health (NYSE:EHC) with a Strong Buy and raises the price target from $72 to $80.
Benzinga Newsdesk

Mon May 1, 2023

Deutsche Bank Maintains Buy on Encompass Health, Raises Price Target to $73

Deutsche Bank analyst Pito Chickering maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $70 to $73.
richadhand@benzinga.com

Mon May 1, 2023

Stephens & Co. Maintains Overweight on Encompass Health, Raises Price Target to $74

Stephens & Co. analyst Scott Fidel maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $70 to $74.
richadhand@benzinga.com

Mon May 1, 2023

Credit Suisse Maintains Outperform on Encompass Health, Raises Price Target to $76

Credit Suisse analyst Jonathan Yong maintains Encompass Health (NYSE:EHC) with a Outperform and raises the price target from $73 to $76.
Benzinga Newsdesk

Mon May 1, 2023

Mizuho Maintains Buy on Encompass Health, Raises Price Target to $74

Mizuho analyst Ann Hynes maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $69 to $74.
Benzinga Insights

Fri Apr 28, 2023

Where Encompass Health Stands With Analysts
Benzinga Newsdesk

Fri Apr 28, 2023

B of A Securities Maintains Buy on Encompass Health, Raises Price Target to $74

B of A Securities analyst Kevin Fischbeck maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $69 to $74.

Christie Edward M III, Director

Mon Nov 27, 2023

EHC Recent Insider Trades and Stock Chart

997 shares awarded
COLTHARP DOUGLAS E, EVP & Chief Financial Officer

Mon Nov 13, 2023

EHC Recent Insider Trades and Stock Chart

11,215 shares sold